Overview
Toxikon is an ISO 17025-accredited global preclinical Contract Research Organization that conducts safety studies for the medical device and biopharmaceutical industries, as well as academic research centers to deliver exceptional product development services from concept to final product. With more than 40 years of industry expertise, Toxikon provides testing services to meet FDA/ISO/ICH, OECD, USP and Japan’s MHLW standards. Services include a complete range of PK, TK, ADME and toxicology studies and carcinogenicity, bioavailability, chemical characterization, impurities analysis and synthesis, bioanalytical and microbiology assays. Toxikon operates a 125,000 square-foot facility at their headquarters in Bedford, Massachusetts and serves over 1,500 customers in more than 60 countries.